Covagen And Tanabe Research Laboratories U.S.A., Inc. Expand Strategic Research Collaboration For Development Of Bispecific FynomAbs
11/21/2013 6:37:21 AM
More...
|
Covagen Names Elias Papatheodorou Chief Business Officer
4/15/2013 6:25:34 AM
More...
|
Covagen Inks $146 Million Pact With Mitsubishi Tanabe Pharma Corporation
10/17/2012 7:20:48 AM
More...
|
Covagen Nominates Bispecific TNF/IL-17A Inhibitor as Drug Candidate to Enter Preclinical Development
12/12/2011 8:47:56 AM
More...
|
Sir Gregory Winter Joins Covagen's Scientific Advisory Board
9/20/2011 10:16:23 AM
More...
|
Covagen Nominates Franz Hefti as New Member of the Board of Directors
5/16/2011 11:14:54 AM
More...
|
Covagen Nominates Frank Walsh as Executive Chairman and Appoints Mathias Locher as Chief Development Officer
3/7/2011 10:37:01 AM
More...
|
Covagen Closes Series A Financing Round of CHF 6.3 Million
11/29/2010 7:13:47 AM
More...
|
Covagen and Roche (RHHBY) Extend Collaboration on the Use of Fynomers in Drug Discovery
11/8/2010 1:18:12 PM
More...
|
Thierry Hercend joins Covagen's Scientific Advisory Board
4/7/2010 2:41:42 PM
More...
|
|